Key Highlights

  • Revenue for the third quarter of 2026 hit USD 114.4 million, a 104% jump from USD 56.0 million, and the largest quarterly figure since the third quarter of 2014.
  • Diluted Earnings came to USD 0.34 a share, or USD 13.3 million in total, a 35% decline, as the comparison quarter had booked a USD 12.6 million non-cash tax gain.
  • Adjusted EBITDA jumped 87% to USD 19.5 million, while full-year 2026 Revenue guidance was lifted to USD 382 million to USD 390 million from USD 360 million to USD 370 million.
  • International Chemistry revenue hit USD 28.4 million, or 25% of the total, up from USD 2.2 million a year earlier, driven by work in the Middle East.

A Twelve-Year Revenue Peak and a Raised Full-Year Target

Flotek Industries (NYSE:FTK), a Houston Business that pairs oilfield chemistry with near real-time data analytics, released third-quarter 2026 figures on November 3, 2026. Revenue more than doubled from USD 56.0 million to USD 114.4 million, with both the Chemistry Technologies and Data Analytics segments up 104%. Nine-month revenue advanced 67% to USD 283.8 million. For the second time this year the company lifted 2026 guidance, now to USD 382 million to USD 390 million of revenue and USD 59 million to USD 62 million of adjusted EBITDA, up from USD 50 million to USD 54 million before. The guidance is a management expectation rather than a reported result.

Where the Growth Stalled at the Profit and Margin Lines

Gross profit increased 54% to USD 27.4 million, yet gross margin fell to 24% from 32%. Management mainly blames a USD 7.8 million decline in revenue tied to minimum purchase commitments under its Supply deal with ProFrac Services. That revenue carried no matching cost, and actual related-party sales ran ahead of the minimum. Related-party Chemistry revenue climbed 87% to USD 50.3 million. Net Income comparisons are also skewed because the prior year held the USD 12.6 million tax benefit. Revenue, net income and adjusted EBITDA each rose in every quarter of 2026. Data Analytics produced 45% of Gross Profit from only 16% of revenue, and SG&A increased to USD 8.5 million on Stock Compensation and Bonus costs.

Customer Dependence, the New Term Loan and the 2027 Capital Plan

Roughly 44% of third-quarter revenue came from the related party by simple arithmetic. Risk factors cited include reliance on ProFrac, indebtedness, covenant compliance, Middle East operations and pending Shareholder litigation. A term loan closed in September should partly fund 2027 capital spending of USD 15 million to USD 20 million, directed toward measurement instruments, gas conditioning equipment and Manufacturing capacity. Management also wants to extend its technology into behind-the-meter power generation. The material reviewed has no peer comparison. An Earnings Call was set for November 4, 2026 at 9:00 a.m. CST. Watch how the capital plan is executed, gross margin trends and whether international Chemistry sales keep growing beyond this quarter.

Where Things Stand

The revenue surge is real and broad, though the 104% figure needs context. Flotek Industries (NYSE:FTK) more than doubled sales, raised guidance and lifted adjusted EBITDA 87%, while GAAP net income fell because last year's quarter held a tax benefit. Margins narrowed and much of the sales rely on a single related party. The next checkpoints are fourth-quarter results measured against the raised outlook and how the term loan funds the Data Analytics expansion.